 | ||||
 | | | | |
 |  |  |  |  | ||||||
| | | | | | | | | | |
 | |||||||
 |  | | | ||||
| |||||||
| | | | | | | |
|
| |||
| | | | |
4.Our Publications and References (Recent issues in English are selected) Nakamura H, Kawagishi H, Watanabe A, Sugimoto K, Maruyama M, Mizutani S, and Sugimoto M "Cooperative role of the RNA-binding proteins Hzf and HuR in p53 activation." Molecular Cellular Biology, 10, 1997-2009, 2011
Ito T, Takii T, Maruyama M, Hayashi D, Wako T, Asai A, Horita Y, Taniguchi K, Yano I, Yamamoto S, Onozaki K "Effectiveness of BCG vaccination to aged mice." Immun Ageing, 7:12-12,2010
Kawagishi H, Nakamura H, Maruyama M, Mizutani S, Sugimoto K, Takagi M, and Sugimoto M "ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA." Cancer Research, 70(11): 4749-4758, 2010
Jia YJ, Asai A, Sakabe I, and Maruyama M "Rat Monoclonal Antibodies against New Guanine Nucleotide Exchange Factor (GEF), mouse Zizimin2." Hybridoma, 29(3): 205-209. 2010
Maruyama M "214I9 against mouse Zizimin2 C-terminal-half fragment." Hybridoma, 29(3): 273-273, 2010
Nakamura H, Asai A, Maruyama M and Sugimoto M "Production of Rat Monoclonal Antibodies Against RNA-binding Protein, Hzf." Hybridoma, 29(1):7-11, 2010
Maruyama M, Wakoh T, Terauchi K, Sugimoto M, and Jun-ichi Shimada "Putative role of a novel p53-dependent cellular senescence related gene, TARSH in tumor suppression". The Journal of Nutrition, Health and Aging, 13(suppl.1), S553, 2009
Wakoh T, Uekawa N, Terauchi K, Sugimoto M, Ishigami A, Shimada J, and Maruyama M: "Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression." Biochemical and Biophysical Research Communications, 380, 807-812. 2009
Wakoh T, Sugimoto M, Terauchi K, Shimada J,and Maruyama M: "A novel p53-dependent apoptosis function of TARSH in tumor development." Nagoya J Med Sci. 71(3-4), 109-114. 2009
Kawagishi H, Wakoh T, Uno H, Maruyama M, Moriya A, Morikawa S, Okano H, Sherr C.J., Takagi M, and Sugimoto M. "Hzf regulates adipogenesis through translational control of C/EBPα.." The EMBO Journal , 27(10), 1481-1490, 2008
Uekawa N, Nishioka T, Terauchi K, Ohta S, Sugimoto M, Shimada J, and Maruyama M "Generation and Characterization of Novel Monoclonal Antibodies Against Murine and Human TARSH Proteins " Hybridoma. 26(6): 381-386, 2007
Maruyama M "M38, MS6, and MS13 Against Murine TARSH C Terminal-Half Fragment " Hybridoma. 26(6): pp441-442, 2007
Maruyama M "H165, H56, and H69 Against Murine and Human TARSH C Terminal-Half Fragment " Hybridoma. 26(6): pp443-444, 2007
Ujike-Asai A，Okada A，Du Y，Maruyama M，Yuan X，Ishikawa F，Motoo Y，Isobe K and Nakajima H "Large defects of type I allergic response in telomerase reverse transcriptase knockout mice" J Leukoc Biol. 82:429-435, 2007
Mitsuda N, Yamagata HD, Zhong W, Aoto M, Akatsu H, Uekawa N, Kamino K, Taguchi K, Yamamoto T, Maruyama M, Kosaka K, Takeda M, Kondo I,and Miki T. "A novel alternative splice variant of nicastrin and its implication in Alzheimer disease." Life Sci. 78, 2444-2448 , 2006
Murata Y*, Wakoh T*, Uekawa N, Sugimoto M, Asai A, Miyazaki T and Maruyama M. "Death-associated protein 3 regulates cellular senescence through oxidative stress response" FEBS Lett. 580, 6093-6099 , 2006 (*equal contribution)
Terauchi K, Shimada J, Uekawa N, Yaoi T, Maruyama M and Fushiki S
Uekawa N,Terauchi,K Nishikimi A, Shimada J, and Maruyama M Biochem Biophys Res Commun, 329, 1031-1038, 2005
Novobrantseva T, Xu S, Tan J, Maruyama M, Schwers S, Pelanda R, and Lam KP Int Immunol. 17, 343-350, 2005
Nishikimi A*, Meller N*, Uekawa N, Isobe K, Schwartz MA and Maruyama M FEBS Lett. 579, 1039-1046, 2005 (*equal contribution)
Uekawa N, Nishikimi, A Isobe K, Iwakura Y, and Maruyama M.
Oberdoerffer P, Otipoby K, Maruyama M, and Rajewsky K Nucleic Acids Res. 31, e140, 2003
Maruyama M, Lam KP, and Rajewsky K
(References) *Stephan Martin and Chris Goodnow *Garnett Kelsoe " Remembrance of things past" (N & V)
(Other major publications) * Maruyama M., Shibuya H., Harada H., Hatakeyama M., Seiki M., Fujita T., Inoue J.I., Yoshida M. and Taniguchi T. "Evidence for Aberrant Activation of the Interleukin-2 Autocrine Loop by HTLV-1-Encoded p40x and T3/Ti Complex Triggering" Cell, vol.48, 343 - 350, (1987)
* Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T. and Taniguchi T "Regulated Expression of a Gene Encoding a Nuclear Factor, IRF-1, That Specifically Binds to IFN-γ Gene Regulatory Element" Cell, Vol.54, 903 - 913, (1988)
* Maruyama M., Fujita T. and Taniguchi T. "Sequence of a cDNA coding for Human IRF-1"
* Harada H., Fujita F., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., and Taniguchi T. "Structurally Similar but Functionally Distinct Factors, IRF-1 and IRF-2, Bind to the Same Regulatory Elements of IFN and IFN-Induced Genes" Cell, Vol.58, 729 - 739, (1989)
* Miyazaki T., Maruyama M., Yamada G., Hatakeyama M. and Taniguchi T. "The integrity of the conserved "WS-motif" common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction"
* Ogawa E., Maruyama M., Kagoshima H., Inuzuka M., Lu J., Satake M., Shigesada K. and Ito. Y. " PEBP2/PEA2 represents α new family of transcription factor homologous to the products of the Drosophila runt and the human AML1." Proc. Natl. Acad. Sci USA 90, 6859 - 6863, (1993)
* Bae S.C., Ogawa E., Maruyama M., Oka H., Satake M., Shigesada K., Jenkins N.A., Gilbert D.J., Copeland N.G. and Ito. Y. "PEBP2αB/Mouse AML1 consists of multiple isoforms that possess differential transactivation potentials." Mol. Cell. Biol., 14, 3242 - 3252, (1994)
* Lu J., Maruyama M., Satake M., Bae S.C., Ogawa E., Kagoshima H., Shigesada K. and Ito Y. " Subcellular Localization of the α and β Subunits of Acute Myeloid Leukemia-linked Transcription Factor PEBP2/CBF."
* Ahn M.Y., Bae S.C., Maruyama M. and Ito Y. "Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFα gene family." Gene, 68(2): 279-280, (1996) | ||
| | |
| | | | |
| ||
| | |
